Demystifying the medical management of nephrolithiasis.
Publication
, Journal Article
Lipkin, ME; Preminger, GM
Published in: Rev Urol
2011
Nephrolithiasis is a common problem associated with significant costs to the health care system. Its prevalence continues to increase, particularly in women, which is attributed to changes in diet and lifestyle. The costs associated with the evaluation and management of nephrolithiasis in the United States has been estimated to be $1.83 billion, and, without any intervention, the risk of recurrence is high. This article reviews the management options for nephrolithiasis including a new formulation of potassium citrate, Urocit®-K 15 mEq, that allows for dosing flexibility which can lead to improved compliance and tolerability.
Duke Scholars
Published In
Rev Urol
EISSN
2153-8182
Publication Date
2011
Volume
13
Issue
1
Start / End Page
34 / 38
Location
United States
Citation
APA
Chicago
ICMJE
MLA
NLM
Lipkin, M. E., & Preminger, G. M. (2011). Demystifying the medical management of nephrolithiasis. Rev Urol, 13(1), 34–38.
Lipkin, Michael E., and Glenn M. Preminger. “Demystifying the medical management of nephrolithiasis.” Rev Urol 13, no. 1 (2011): 34–38.
Lipkin ME, Preminger GM. Demystifying the medical management of nephrolithiasis. Rev Urol. 2011;13(1):34–8.
Lipkin, Michael E., and Glenn M. Preminger. “Demystifying the medical management of nephrolithiasis.” Rev Urol, vol. 13, no. 1, 2011, pp. 34–38.
Lipkin ME, Preminger GM. Demystifying the medical management of nephrolithiasis. Rev Urol. 2011;13(1):34–38.
Published In
Rev Urol
EISSN
2153-8182
Publication Date
2011
Volume
13
Issue
1
Start / End Page
34 / 38
Location
United States